🇺🇸 Influenzae vaccine in United States

41 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 5 reports (12.2%)
  2. Malaise — 5 reports (12.2%)
  3. Therapeutic Product Effect Decreased — 5 reports (12.2%)
  4. Contraindicated Product Administered — 4 reports (9.76%)
  5. Drug Ineffective — 4 reports (9.76%)
  6. Epicondylitis — 4 reports (9.76%)
  7. Musculoskeletal Pain — 4 reports (9.76%)
  8. Rheumatoid Arthritis — 4 reports (9.76%)
  9. Condition Aggravated — 3 reports (7.32%)
  10. Pain — 3 reports (7.32%)

Source database →

Influenzae vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Influenzae vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Influenzae vaccine in United States?

PT Bio Farma is the originator. The local marketing authorisation holder may differ — check the official source linked above.